I agree that this site is using cookies. You can find further informations here.
X
Kriachok, Iryna
25  results:
Search for persons X
?
1

Distribution of lymphoma subtypes in Ukraine according to t..:

Kriachok, Iryna ; Stepanishyna, Yana ; Skrypets, Tetiana...
Hematological Oncology.  41 (2022)  1 - p. 196-200 , 2022
Link: https://doi.org/10.1002/..
 
?
2

Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:

Ghia, Paolo ; Pluta, Andrzej ; Wach, Małgorzata...
HemaSphere.  6 (2022)  12 - p. e801 , 2022
Link: https://doi.org/10.1097/..
 
?
3

Effect of prior treatments on selinexor, bortezomib, and de..:

Mateos, Maria V. ; Gavriatopoulou, Maria ; Facon, Thierry...
Journal of Hematology & Oncology.  14 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
4

Effect of age and frailty on the efficacy and tolerability ..:

Auner, Holger W. ; Gavriatopoulou, Maria ; Delimpasi, Sosana...
American Journal of Hematology.  96 (2021)  6 - p. 708-718 , 2021
Link: https://doi.org/10.1002/..
 
?
5

Peripheral neuropathy symptoms, pain, and functioning in pr..:

Sanchez, Larysa ; Leleu, Xavier ; Beaumont, Jennifer L....
American Journal of Hematology.  96 (2021)  10 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
6

Selinexor, bortezomib, and dexamethasone versus bortezomib ..:

Richard, Shambavi ; Chari, Ajai ; Delimpasi, Sosana...
American Journal of Hematology.  96 (2021)  9 - p. 1120-1130 , 2021
Link: https://doi.org/10.1002/..
 
?
7

PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL MARKERS IN PATIENTS..:

Martynchyk, Arina ; Gurianov, Vitaliy ; Kriachok, Iryna
EUREKA: Health Sciences.  1 (2018)  - p. 26-33 , 2018
Link: https://doi.org/10.21303..
 
?
8

THE COMPLICATIONS OF DIFFERENTIAL DIAGNOSTICS OF HODGKIN LY..:

Kriachok, Iryna ; Ulianchenko, Katerina
EUREKA: Health Sciences.  6 (2016)  - p. 63-68 , 2016
Link: https://doi.org/10.21303..
 
?
9

Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:

Ghia, Paolo ; Pluta, Andrzej ; Wach, Malgorzata...
HemaSphere. -6 : 12 (2022), p. 1-10. -Hemasphere. - 2572-9241.  , 2022
Link: https://hdl.handle.net/2..
 
?
10

Distribution of lymphoma subtypes in Ukraine according to t..:

Kriachok, Iryna ; Stepanishyna, Yana ; Skrypets, Tetiana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087250/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:

Ghia, Paolo ; Pluta, Andrzej ; Wach, Małgorzata...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666115/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Effect of prior treatments on selinexor, bortezomib, and de..:

Mateos, Maria V ; Gavriatopoulou, Maria ; Facon, Thierry...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045319/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Selinexor, bortezomib, and dexamethasone versus bortezomib ..:

Richard, Shambavi ; Chari, Ajai ; Delimpasi, Sosana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457116/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Effect of Age and Frailty on the Efficacy and Tolerability ..:

Auner, Holger W ; Gavriatopoulou, Maria ; Delimpasi, Sosana...
American Journal of Hematology.  , 2021
Link: http://hdl.handle.net/10..
 
?
15

Selinexor, bortezomib, and dexamethasone versus bortezomib ..:

Richard, Shambavi ; Chari, Ajai ; Delimpasi, Sosana...
American Journal of Hematology.  , 2021
Link: http://hdl.handle.net/10..
 
1-15